RCUS (RCUS) Stock Price & Analysis
RCUS (RCUS) rose 0.00% to USD 28.42 as of July 25, 2026 at 04:33 UTC, according to Nexqual real-time market data.
RCUS last closed at USD 28.42; the session ranged USD 28.33–30.17 on volume of 874,078 shares. Market capitalization is —, with a 52-week range of USD 8.84–31.74 (NYQ). Source: Nexqual, July 25, 2026 at 04:33 UTC.
Key Statistics (as of July 25, 2026 at 04:33 UTC)
| Price | USD 28.42 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 28.42 |
| Open | USD 28.42 |
| Day Range | USD 28.33 – 30.17 |
| 52-Week Range | USD 8.84 – 31.74 |
| Volume | 874,078 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (RCUS)
Nexqual's technical model rates RCUS "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 04:33 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 53.6 (neutral) |
| vs SMA50 | Above (USD 26.47) |
| MACD | 0.58 (positive) |
From RCUS's Latest SEC 10-K Filing (filed 2026-02-25)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals, Inc. | USD 20.81 | ▼ 5.62% |
| ARVN | Arvinas, Inc. | USD 8.03 | ▼ 2.78% |
| DNLI | Denali Therapeutics Inc. | USD 23.11 | ▼ 2.24% |
| IDYA | IDEAYA Biosciences, Inc. | USD 35.4 | ▲ 1.14% |
| KURA | Kura Oncology, Inc. | USD 10.39 | ▼ 1.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:33 UTC. This page is informational and not investment advice.